Goldman Sachs Raises Price Target on Humana (HUM) After CEO Meeting
Tweet
Share
E-mailGet Alerts HUM Hot Sheet
Price: $378.88 -0.49%
Rating Summary:
15 Buy, 19 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
15 Buy, 19 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs raised its price target on Buy-rated Humana (NYSE: HUM) from $101 to $104 following recent meetings with CEO Mike McAllister in California. The firm maintained EPS at $8.45/$8.25/$9.10 versus Street $8.44/$7.98/$8.90.
The firm comments, "Humana sees continued favorable trends across its businesses with MA growth the key but with also a more positive view on commercial pricing as compared with other recent perspectives."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $89.03 yesterday.
The firm comments, "Humana sees continued favorable trends across its businesses with MA growth the key but with also a more positive view on commercial pricing as compared with other recent perspectives."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $89.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana names Dr. Shantanu Nundy as chief medical officer
- Clear Street Reiterates Buy Rating on Anterix Inc. (ATEX)
- DA Davidson Starts Everus (ECG) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
